Skip to main content

Wounds

3
Pipeline Programs
12
Companies
11
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
2
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

10 companies ranked by most advanced pipeline stage

B. Braun
B. BraunGermany - Melsungen
1 program
1
LavaseptPhase 41 trial
Active Trials
NCT01153620Completed61Est. Jan 2011
NanoVibronix
NanoVibronixIsrael - Nesher
1 program
1
PainShieldPhase 41 trial
Active Trials
NCT00737425Unknown80
Biocorp
BiocorpFrance - Issoire
2 programs
1
AR/101Phase 21 trial
hydrophilic-based dressingN/A1 trial
Active Trials
NCT01921725Completed60
NCT02839226Unknown60Est. Dec 2017
Medtronic
MedtronicNJ - Phillipsburg
2 programs
application of autologous platelet gelN/A1 trial
autologous platelet gelN/A1 trial
Active Trials
NCT00199992Completed8Est. Aug 2005
NCT00125086Completed4Est. Feb 2006
Integra LifeSciences
Integra LifeSciencesAustralia - Clayton
1 program
ACell ArmN/A1 trial
Active Trials
NCT03632954Terminated37Est. Jan 2020
Kerecis
KerecisIceland - Isafjordur
1 program
Kerecis Fish Skin GraftN/A1 trial
Active Trials
NCT06384183Enrolling By Invitation600Est. Jun 2027
Solventum
SolventumMN - St. Paul
1 program
VAC® Therapy SystemN/A1 trial
Active Trials
NCT00234559Withdrawn0Est. Aug 2007
Organogenesis
OrganogenesisCANTON, MA
1 program
VCT-01N/A1 trial
Active Trials
NCT01292122Terminated3Est. Sep 2012
Carbon Biosciences
Carbon BiosciencesMA - Waltham
1 program
hydrophilic-based dressingN/A
ConvaTec
ConvaTecNJ - Bridgewater
1 program
Engenex™ pump and Bio-Dome™ Wound DressingPHASE_41 trial
Active Trials
NCT01107821Completed15Est. Sep 2010

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
B. BraunLavasept
ConvaTecEngenex™ pump and Bio-Dome™ Wound Dressing
NanoVibronixPainShield
BiocorpAR/101
KerecisKerecis Fish Skin Graft
Integra LifeSciencesACell Arm
Biocorphydrophilic-based dressing
OrganogenesisVCT-01
SolventumVAC® Therapy System
Medtronicautologous platelet gel
Medtronicapplication of autologous platelet gel

Clinical Trials (11)

Total enrollment: 928 patients across 11 trials

The Antiseptic Efficacy and Tolerability of Lavasept® 0.04% on Acute Traumatic Wounds

Start: Aug 2010Est. completion: Jan 201161 patients
Phase 4Completed
NCT01107821ConvaTecEngenex™ pump and Bio-Dome™ Wound Dressing

Negative Pressure Wound Therapy With the Engenex™-Pump and Bio-Dome™ Dressing, an Evaluation

Start: Feb 2010Est. completion: Sep 201015 patients
Phase 4Completed

Safety and Efficacy Study of Pain Shield Device to Treat Subjects Following Laparoscopic-Assisted Abdominal Surgery

Start: Sep 200880 patients
Phase 4Unknown

Safety and Efficacy of Topical AR/101 Compared With Placebo, in Accelerating Granulation Tissue Formation of Hard-to-heal Wounds

Start: Aug 2016Est. completion: Dec 201760 patients
Phase 2Unknown
NCT06384183KerecisKerecis Fish Skin Graft

Kerecis Real-World Fish Skin Graft Registry

Start: Aug 2024Est. completion: Jun 2027600 patients
N/AEnrolling By Invitation

Cytal® Wound Matrix and MicroMatrix® Wound Study

Start: Dec 2018Est. completion: Jan 202037 patients
N/ATerminated
NCT01921725Biocorphydrophilic-based dressing

The Clinical Application and Efficacy Verification of an Innovative Carbon Fiber Dressing

Start: May 201360 patients
N/ACompleted

Safety Study of VCT-01™ in Split-Thickness Skin Graft Donor Site Wounds

Start: Jun 2011Est. completion: Sep 20123 patients
N/ATerminated
NCT00234559SolventumVAC® Therapy System

Trial of Vacuum Assisted Closure® Therapy Versus Control Therapy in Angiogenesis

Start: Sep 2005Est. completion: Aug 20070
N/AWithdrawn
NCT00125086Medtronicautologous platelet gel

Platelets for Acute Wound Healing

Start: Jul 2005Est. completion: Feb 20064 patients
N/ACompleted
NCT00199992Medtronicapplication of autologous platelet gel

Platelets in Acute Wounds: A Pilot Study (PAWS)

Start: Jan 2005Est. completion: Aug 20058 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

12 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.